Nature Communications (Oct 2024)

Transcriptional coactivator MED15 is required for beta cell maturation

  • Alex Z. Kadhim,
  • Ben Vanderkruk,
  • Samantha Mar,
  • Meixia Dan,
  • Katarina Zosel,
  • Eric E. Xu,
  • Rachel J. Spencer,
  • Shugo Sasaki,
  • Xuanjin Cheng,
  • Shannon L. J. Sproul,
  • Thilo Speckmann,
  • Cuilan Nian,
  • Robyn Cullen,
  • Rocky Shi,
  • Dan S. Luciani,
  • Bradford G. Hoffman,
  • Stefan Taubert,
  • Francis C. Lynn

DOI
https://doi.org/10.1038/s41467-024-52801-9
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Mediator, a co-regulator complex required for RNA Polymerase II activity, interacts with tissue-specific transcription factors to regulate development and maintain homeostasis. We observe reduced Mediator subunit MED15 expression in endocrine hormone-producing pancreatic islets isolated from people living with type 2 diabetes and sought to understand how MED15 and Mediator control gene expression programs important for the function of insulin-producing β-cells. Here we show that Med15 is expressed during mouse β-cell development and maturation. Knockout of Med15 in mouse β-cells causes defects in β-cell maturation without affecting β-cell mass or insulin expression. ChIP-seq and co-immunoprecipitation analyses found that Med15 binds β-cell transcription factors Nkx6-1 and NeuroD1 to regulate key β-cell maturation genes. In support of a conserved role during human development, human embryonic stem cell-derived β-like cells, genetically engineered to express high levels of MED15, express increased levels of maturation markers. We provide evidence of a conserved role for Mediator in β-cell maturation and demonstrate an additional layer of control that tunes β-cell transcription factor function.